Beyond the Abstract - Degarelix: A new approach for the treatment of prostate cancer, by Bo-Eric Persson, MD
Friday, 06 November 2009
BERKELEY, CA (UroToday.com) - Gonadotrophin-releasing hormone (GnRH) agonists are currently the ‘standard of care’ for androgen deprivation therapy (ADT) in prostate cancer.
Login to read more...
|
Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended - Abstract
Friday, 06 November 2009 Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC, USA.
read more
|
Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: Analysis of the SEARCH database - Abstract
Friday, 06 November 2009 Department of Urology, Stanford University Medical Center, Stanford, California; Urology Section, Department of Surgery, Veterans Affairs Medical Center, Palo Alto, California.
read more
|
Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy - Abstract
Friday, 06 November 2009 Institute for Molecular Nanotechnology, Recklinghausen, Lienen, Germany.
read more
|
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study - Abstract
Friday, 06 November 2009 Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
read more
|
Peripheral zone sonographic changes of the prostate - Abstract
Friday, 06 November 2009 Urology Department, Urology and Nephrology Center, Mansoura, Egypt.
read more
|
Managing uncertainty about treatment decision making in early stage prostate cancer: A randomized clinical trial - Abstract
Friday, 06 November 2009 School of Nursing, University of NC at Chapel Hill, USA.
read more
|
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy - Abstract
Friday, 06 November 2009 Department of Radiation, Institut Gustave-Roussy, Villejuif.
read more
|
Editorial - Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy
Thursday, 05 November 2009
BERKELEY, CA (UroToday.com) - Transrectal ultrasound with prostate biopsy (TRUS/Bx) remains the method for detection of prostate cancer (CaP) in men with an elevated PSA or abnormal digital rectal examination.
Login to read more...
|
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy - Abstract
Thursday, 05 November 2009 Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
read more
|
Characterization of the anatomical extension pattern of localized prostate cancer arising in the peripheral zone - Abstract
Thursday, 05 November 2009 Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
read more
|
'Prostatic evasive anterior tumours': the role of magnetic resonance imaging - Abstract
Thursday, 05 November 2009 Department of Urology and Joint, University Health Network, University of Toronto, Toronto, ON, Canada.
read more
|
Medical history, body size, and cigarette smoking in relation to fatal prostate cancer - Abstract
Thursday, 05 November 2009 Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Avenue, Portland, OR, USA.
read more
|
Robot assisted laparoscopic prostatectomy: initial tips and tricks - Abstract
Thursday, 05 November 2009 Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
read more
|
Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone - Abstract
Thursday, 05 November 2009 Dana-Farber Cancer Institute, Boston, MA Tulane Cancer Center, New Orleans, LA.
read more
|
PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation - Abstract
Thursday, 05 November 2009 Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI.
read more
|
Chemo-radiation before prostate removal may prevent cancer recurrence
Wednesday, 04 November 2009
PORTLAND, OR, USA (News Release) - November 4, 2009
read more
|
Shorter radiation course as effective as standard therapy for prostate cancer recurrence
Wednesday, 04 November 2009
CHICAGO, IL, USA (News Release) - November 3, 2009
read more
|
Shorter radiation course stops cancer growth in high-risk prostate cancer patients
Wednesday, 04 November 2009
CHICAGO, IL, USA (News Release) - November 3, 2009
read more
|
Editorial - Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort
Wednesday, 04 November 2009 BERKELEY, CA (UroToday.com) - In the online edition of the Journal of Clinical Oncology, Dr. William Shappley and associates reported on a prospective cohort of men with prostate cancer (CaP) who were followed with active surveillance with deferred treatment (DT) intervention.
Login to read more...
|
Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage - Abstract
Wednesday, 04 November 2009 Department of Pathology, Pitie-Salpetriere Hospital, GHU Est, University PMC Paris VI, Paris, France.
read more
|
Drug management of prostate cancer: Prevalence and consequences of renal insufficiency - Abstract
Wednesday, 04 November 2009 Nephrology, Hôpital Pitié-Salpêtrière, Paris, France.
read more
|
Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus doxorubicin in the treatment of metastatic castration-resistant prostate cancer - Abstract
Wednesday, 04 November 2009 Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY.
read more
|
The mechanism of action of estrogen in castration-resistant prostate cancer: Clues from hormone levels - Abstract
Wednesday, 04 November 2009 Urologic Oncology Program, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.
read more
|
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75 - Abstract
Wednesday, 04 November 2009 Division of Urology, Department of Surgery and Duke Prostate Center, Duke University Medical Center, Durham, North Carolina.
read more
|
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis - Abstract
Wednesday, 04 November 2009 Department of Epidemiology, National Cancer Institute Regina Elena, Rome, Italy.
read more
|
Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees - Abstract
Wednesday, 04 November 2009 Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden.
read more
|
Factors associated with prostate cancer patients' and their spouses' satisfaction with a family-based intervention - Abstract
Wednesday, 04 November 2009 College of Nursing, Wayne State University, Detroit, Michigan; School of Nursing, University of Michigan, Ann Arbor.
read more
|
Late rectal toxicity after prostate brachytherapy: Influence of supplemental external beam radiation on dose-volume histogram analysis - Abstract
Wednesday, 04 November 2009 Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL.
read more
|
Task force develops new radiation guidelines for brachytherapy
Tuesday, 03 November 2009
PHILADELPHIA, PA, USA (News Release) - November 3, 2009
read more
|